{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:08:40Z","timestamp":1779253720955,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P3-0343"],"award-info":[{"award-number":["P3-0343"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["J3-2536"],"award-info":[{"award-number":["J3-2536"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2026.120672","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:19:05Z","timestamp":1770682745000},"page":"120672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LDLR and APOB pathogenic variants predict discordant TSH effect on LDL-C"],"prefix":"10.1016","volume":"415","author":[{"given":"Jan","family":"Kafol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaka","family":"Sikonja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matej","family":"Mlinaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cugalj Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Pricop-Jeckstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Drole Torkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tevz","family":"Gorjanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra\u017e","family":"Petek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreja","family":"Lakner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jernej","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-9869","authenticated-orcid":false,"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120672_bib1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120672_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120672_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120672_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0025-7125(16)30179-1","article-title":"Secondary causes of hyperlipidemia","volume":"78","author":"Stone","year":"1994","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120672_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.35772\/ghm.2020.01078","article-title":"Secondary dyslipidemia: its treatments and association with atherosclerosis","volume":"3","author":"Yanai","year":"2021","journal-title":"Glob Health Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120672_bib6","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.78.4.2591","article-title":"Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo","volume":"78","author":"Thompson","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.120672_bib7","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding Protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120672_bib8","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2012-1133","article-title":"Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones","volume":"97","author":"Wang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120672_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2478\/jomb-2014-0044","article-title":"Association between thyroid hormones, lipids and oxidative stress markers in subclinical hypothyroidism","volume":"34","author":"Cheserek","year":"2015","journal-title":"J Med Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.120672_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fendo.2019.00868","article-title":"Hashimoto thyroiditis and dyslipidemia in childhood: a review","volume":"10","author":"Vukovic","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120672_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4274\/jcrpe.3719","article-title":"Association of subclinical hypothyroidism with dyslipidemia and increased carotid intima-media thickness in children","volume":"9","author":"Unal","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120672_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.13752","article-title":"Mild subclinical hypothyroidism is associated with paediatric dyslipidaemia","volume":"89","author":"Dahl","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120672_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/js.2017-00471","article-title":"Mild hypothyroidism in childhood: who, when, and how should be treated?","volume":"2","author":"Vigone","year":"2018","journal-title":"J Endocr Soc"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120672_bib14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klancar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120672_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: the Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120672_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.gim.2022.06.010","article-title":"Universal screening for familial hypercholesterolemia in 2 populations","volume":"24","author":"Sustar","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.atherosclerosis.2026.120672_bib17","doi-asserted-by":"crossref","first-page":"zwaf352","DOI":"10.1093\/eurjpc\/zwaf352","article-title":"Proposal of a familial hypercholesterolemia pediatric diagnostic score (FH-PeDS)","volume":"20","author":"Kafol","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2026.120672_bib18","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120672_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120672_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120672_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jc.2011-2532","article-title":"Update in lipid alterations in subclinical hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120672_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/BJ20060914","article-title":"SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR","volume":"400","author":"Wong","year":"2006","journal-title":"Biochem J"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120672_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year Follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.120672_bib24","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120672_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41390-024-03691-6","article-title":"Obesity-related subclinical hypothyroidism in childhood: elevated triglycerides but not basal metabolic rate","volume":"98","author":"Tersander","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.atherosclerosis.2026.120672_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4711275","article-title":"The association of thyroid-stimulating hormone (TSH) levels and lipid profile in euthyroid patients with familial hypercholesterolemia","volume":"2023","author":"Heidarpour","year":"2023","journal-title":"BioMed Res Int"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:36:59Z","timestamp":1779251819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S0021915026000389"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120672","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDLR and APOB pathogenic variants predict discordant TSH effect on LDL-C","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120672"}}